NCT05974683View on ClinicalTrials.gov

Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period

NANot yet recruitingINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Autoimmune Diseases

Interventions

DRUG

placebo

Continue use of current basic maintenance treatment of IgG4-RD plus placebo, Follow-up intervals: week 4, week 12, week 24, week 36, week 52

DRUG

mycophenolate mofetil

Use low dose mycophenolate mofetil (0.5g per day) as an add-on therapy of current basic maintenance treatment of IgG4-RD, Follow-up intervals: week 4, week 12, week 24, week 36, week 52

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

collaborator

Beijing Friendship Hospital

OTHER

collaborator

Tongji Hospital

OTHER

lead

Peking Union Medical College Hospital

OTHER

NCT05974683 - Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period | Biotech Hunter | Biotech Hunter